Kubacka R T
University of Pittsburgh School of Pharmacy, Pittsburgh, USA.
J Am Pharm Assoc (Wash). 1996 Apr;NS36(4):257-61, 279. doi: 10.1016/s1086-5802(16)30049-3.
Many health care organizations evaluate drug utilization to improve the quality of patient care, reduce pharmaceutical expenditures, and enhance therapeutic outcomes. The Drug Regimen Review, instituted in 1974 as part of a quality assurance program for the care of Medicaid recipients, has reduced medication use, medication errors, adverse drug reactions, and drug-drug interactions. The Drug Usage Evaluation, a sophisticated analysis of drugs, their uses, and their contributions to various patient outcomes, is performed by member institutions of the Joint Commission on Accreditation of Healthcare Organizations. The 1990 Omnibus Budget Reconciliation Act (OBRA '90) established the Drug Utilization Review (DUR), which was implemented by state Medicaid outpatient prescription programs in 1993. Pharmacists performing DURs must review past patterns of drug misuse, monitor current therapy, and offer patient counseling. Drug utilization reviews have reduced inappropriate drug use and decreased drug costs.
许多医疗保健组织评估药物使用情况，以提高患者护理质量、降低药品支出并增强治疗效果。1974年设立的药物治疗方案审查作为医疗补助受助人护理质量保证计划的一部分，减少了药物使用、用药错误、药物不良反应和药物相互作用。药物使用评估是对药物及其用途以及它们对各种患者治疗效果的贡献进行的深入分析，由医疗保健组织认证联合委员会的成员机构进行。1990年《综合预算协调法案》（OBRA '90）设立了药物使用审查（DUR），该审查于1993年由州医疗补助门诊处方计划实施。进行药物使用审查的药剂师必须审查过去的药物滥用模式、监测当前治疗情况并为患者提供咨询。药物使用审查减少了不适当的药物使用并降低了药品成本。
